Nephron Pharmaceuticals Corporation
Developer and manufacturer of sterile inhalation and 503B outsourcing medication.
Based in SC
🤖
AI Overview
With $1.0M in lobbying spend across 28 quarterly filings, Nephron Pharmaceuticals Corporation is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$1.0M
Total Spend
7
Years Active
1
Firms Hired
6
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $165K |
| 2019 | $180K |
| 2020 | $180K |
| 2021 | $180K |
| 2022 | $180K |
| 2023 | $0 |
| 2025 | $140K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Pharmacy, Manufacturing
- •Issues relating to the regulations around drug manufacturing.
- •Generic drug manufacturing
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.